All posts
Published
September 11, 2025

Healthcare Investment: A Path to Economic Prosperity in the Global South

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

A healthy workforce and population are fundamental to a thriving economy. While the upfront costs of establishing universal healthcare can seem daunting for nations in the Global South, the long-term benefits are undeniable. By improving health outcomes and ensuring access to essential medicines, countries can unlock significant economic potential. This is a strategic investment in human capital that pays dividends in productivity, stability, and sustainable growth.

The Role of Universal Healthcare Schemes & Essential Medicines

Many countries have successfully leveraged policy changes to expand healthcare access. The introduction of Universal Healthcare Schemes (UHS) and National Lists of Essential Medicines (NLEM) are powerful examples. These policies provide a baseline level of care, ensuring that cost-effective medicines are accessible to a wider population. The key to making these initiatives effective lies in linking evidence to policy and medical practice. This is where Health Technology Assessments (HTA) become a game-changer.

Linking Policy to Growth: Key Examples

Thailand is a prime example. Since its establishment in 2007, the HTA body, HITAP, has institutionalized evidence-based practices. By linking health economics to policy, HITAP's recommendations have expanded the NLEM, which serves as the national reimbursement list. This has facilitated coverage for over 95% of Thailand's population under three public health schemes, directly supporting the nation's development goals. (Teerawattananona et.al, 2024)

Vietnam has adopted a similar approach, incorporating HTA outcomes into health insurance decisions since 2014. This strategy has been instrumental in expanding public health services, keeping pace with rapid economic growth and the increasing demands of the labor market. (Lee et.al, 2021).

In Latin America, countries like Brazil (Ortega et.al., 2023) have seen steady gains toward universal coverage through its Unified Health System, even amid fiscal austerity. Colombia (Vergara et.al., 2024) has moved toward a unified, implicitly defined benefits approach. Research in both countries has shown that when benefits policy, payment, and regulation evolve together, access expands, leading to health improvements that accumulate and support human capital formation.

Conclusion

These case studies from Asia and Latin America underscore a critical lesson: universal healthcare and essential benefits are not just social programs; they are vital economic accelerators. By adopting evidence-based frameworks like HTAs, countries in the Global South can make informed decisions that improve health equity and build a stronger, more resilient economy for the future.

Recent News

View All News
APAC

Singapore Puts Energy at the Center

Speyside Group provides a strategic perspective on Singapore's renaming of the Ministry of Trade and Industry to the Ministry of Energy, Trade and Industry (METI), effective October 1, 2026. The analysis examines what this Cabinet-level elevation of energy policy means for data center and AI-infrastructure operators, cross-border power trading under the ASEAN Power Grid, and the institutional signals investors should track through 2027.
Read post
Healthcare

How Do Pharmaceutical Companies Engage Patient Advocacy Groups (PAGs) in Emerging Markets?

Speyside Group provides a strategic perspective on patient advocacy group engagement in emerging markets, examining how multinational pharmaceutical companies structure compliant, locally embedded partnerships across Latin America, Asia, and Africa. Drawing on cases from Brazil, India, and Ghana, the analysis outlines the funding caps, disclosure practices, and neutral-channel strategies that separate durable market access programs from reputational and regulatory risk.
Read post
Public Affairs

Zambia Elections Outlook: A Test for President Hichilema

Speyside Group provides an analytical assessment of the Zambia elections 2026, examining a race that has narrowed significantly since early polling showed President Hakainde Hichilema commanding above 60% support. With the August 13 vote approaching, the emergence of Brian Mundubile and the Tonse-Pamodzi Alliance has transformed what many assumed would be a straightforward incumbency win into a competitive contest, with material implications for investors in Zambia’s mining sector and broader operating environment.
Read post